DETROIT (WXYZ) — Henry Ford Health is now the first health care provider in Michigan — and one of the first in the nation — to offer a new multi-cancer early detection test.
The blood test is called Galleri.
Research shows Galleri can detect a cancer signal shared across more than 50 types of cancer through a single blood draw.
Cancer kills more than 560,000 people each year in the U.S.
Dr. Adnan Munkarah at Henry Ford Hospital says the best chance for anyone to beat the disease is early detection.
"If we are able to detect them earlier, we’ll be able to significantly impact the mortality, the death rate related to cancer, and hopefully have more cures," Munkarah said.
The Galleri test looks at the DNA in a patient's blood to determine if any of it may have come from cancer cells.
The blood test has the ability to detect a shared signal of more than 50 types of cancer, more than 45 of which lack recommended screening tests today. Scroll below to see the list of cancers that can be detected.
Munkarah says his team is ecstatic to announce the arrival of Galleri.
He says in his 30 years of cancer research and treatment, the test falls in the top 10% of cancer discoveries he's witnessed.
"This is really a significant revolution in the way that we are looking at cancer screening because traditionally, we’ve had only a number of limited tests available for cancer," Munkarah said.
It’s an unprecedented ability for hopefully an extraordinary amount of lives saved.
Henry Ford says they're making Galleri available to patients who are 22 years and older. They also have a research test currently open.
Types of cancers that can be detected:
Adrenal Cortical Carcinoma
Ampulla of Vater
Anus
Appendix, Carcinoma
Bile Ducts, Distal
Bile Ducts, Intrahepatic
Bile Ducts, Perihilar
Bladder, Urinary
Bone
Breast
Cervix
Colon and Rectum
Esophagus
Esophagogastric Junction
Gallbladder
Gastrointestinal Stromal Tumor
Gestational Trophoblastic Neoplasms
Kidney
Larynx
Leukemia
Liver
Lung
Lymphoma (Hodgkin and Non-Hodgkin)
Melanoma of the Skin
Merkel Cell Carcinoma
Mesothelioma, Malignant Pleural
Nasal Cavity and Paranasal Sinuses
Nasopharynx
Neuroendocrine Tumors of the Appendix
Neuroendocrine Tumors of the Colon and Rectum
Neuroendocrine Tumors of the Pancreas
Oral Cavity
Oropharynx (HPV-Mediated, p16+)
Oropharynx (p16-) and Hypopharynx
Ovary, Fallopian Tube and Primary Peritoneum
Pancreas, exocrine
Penis
Plasma Cell Myeloma and Plasma Cell Disorders
Prostate
Small Intestine
Soft Tissue Sarcoma of the Abdomen and Thoracic Visceral Organs
Soft Tissue Sarcoma of the Head and Neck
Soft Tissue Sarcoma of the Retroperitoneum
Soft Tissue Sarcoma of the Trunk and Extremities
Soft Tissue Sarcoma Unusual Histologies and Sites
Stomach
Testis
Ureter, Renal Pelvis
Uterus, Carcinoma and Carcinosarcoma
Uterus, Sarcoma
Vagina
Vulva
To learn more, visit Henry Ford Health’s website.
